Brief: Agilent, Akoya Biosciences Partners To Drive Multiplex Tissue Assay Development
06/01/2023 13:07
Jan 6 (Reuters) - Agilent Technologies Inc A.N :
* AGILENT AND AKOYA BIOSCIENCES ANNOUNCE PARTNERSHIP TO
DRIVE
MULTIPLEX TISSUE ASSAY DEVELOPMENT FOR BIOPHARMA APPLICATIONS
Source text for Eikon: ID:nBwb8KgSVa
Further company coverage: A.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Akoya Biosciences
See all newsBrief: Akoya Biosciences Inc - On May 20, Receives Unsolicited Acquisition Proposal At $1.40 Per Share From A Third Party- SEC Filing
Akoya Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Akoya Biosciences Q1 Gross Margin 59.3%
Akoya Biosciences Inc expected to post a loss of 20 cents a share - Earnings Preview
Leerink Partners downgrades Quanterix to 'market perform' on Akoya deal risks